Adjuvant Therapy for Soft Tissue Sarcoma

Authors: Scott M. Schuetze MD, PhD* and Michael E. Ray MD, PhD*
View More View Less
  • * From the Department of Medicine, Division of Hematology/Oncology, and the Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan.

Wide surgical excision is the backbone of therapy for localized soft tissue sarcoma and often produces excellent results. Patients with a marginal resection of disease and high-grade or large tumors are at an increased risk of recurrence. Radiation therapy (external beam or brachytherapy) has been shown to reduce the risk of local recurrence of disease and should be offered to patients with large (>5 cm) or high-grade sarcomas, especially if a wide resection cannot be performed. Use of preoperative versus postoperative radiation therapy should be planned, in consultation with a radiation oncologist and a surgical oncologist, before resection of the sarcoma if possible. Chemotherapy using an anthracycline- and ifosfamide-based regimen may improve disease-free and overall survival rates. Chemotherapy appears to be most beneficial for patients with very large (≥10 cm), high-grade sarcomas of the extremity who are at a high risk of experiencing distant recurrence of disease. The effect of adjuvant chemotherapy on overall survival remains controversial. Research is greatly needed to identify the patients who are most likely to benefit from conventional chemotherapy, improve the treatment of retroperitoneal sarcomas, and identify novel agents that may impact the natural history of high-risk soft tissue sarcoma.

Correspondence: Scott M. Schuetze, MD, PhD, 1500 E. Medical Center Dr, C369 Med Inn, Box 0848, Ann Arbor, MI 48109-0848. E-mail: scotschu@med.umich.edu
  • 1

    Jemal A, Tiwari RC, Murray T et al. . Cancer statistics, 2004. CA Cancer J Clin 2004;54:829.

  • 2

    Pisters PW, Leung DH, Woodruff J et al. . Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996;14:16791689.

    • Search Google Scholar
    • Export Citation
  • 3

    Yang JC, Chang AE, Baker AR et al. . Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998;16:197203.

    • Search Google Scholar
    • Export Citation
  • 4

    Abbas JS, Holyoke ED, Moore R, Karakousis CP. The surgical treatment and outcome of soft-tissue sarcoma. Arch Surg 1981;116:765769.

  • 5

    Shiu MH, Castro EB, Hajdu SI, Fortner JG. Surgical treatment of 297 soft tissue sarcomas of the lower extremity. Ann Surg 1975;182:597602.

  • 6

    Rosenberg SA, Tepper J, Glatstein E et al. . The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 1982;196:305315.

    • Search Google Scholar
    • Export Citation
  • 7

    Potter DA, Kinsella T, Glatstein E et al. . High-grade soft tissue sarcomas of the extremities. Cancer 1986;58:190205.

  • 8

    Pisters PW, Harrison LB, Leung DH et al. . Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996;14:859868.

    • Search Google Scholar
    • Export Citation
  • 9

    Pisters PW, Harrison LB, Woodruff JM et al. . A prospective randomized trial of adjuvant brachytherapy in the management of low-grade soft tissue sarcomas of the extremity and superficial trunk. J Clin Oncol 1994;12:11501155.

    • Search Google Scholar
    • Export Citation
  • 10

    Geer RJ, Woodruff J, Casper ES, Brennan MF. Management of small soft-tissue sarcoma of the extremity in adults. Arch Surg 1992;127:12851289.

  • 11

    Coindre JM, Terrier P, Bui NB et al. . Prognostic factors in adult patients with locally controlled soft tissue sarcoma: A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 1996;14:869877.

    • Search Google Scholar
    • Export Citation
  • 12

    Trovik CS, Bauer HC, Alvegard TA et al. . Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer 2000;36:710716.

    • Search Google Scholar
    • Export Citation
  • 13

    Zagars GK, Ballo MT, Pisters PW et al. . Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 225 patients. Cancer. 2003;97:25302543.

    • Search Google Scholar
    • Export Citation
  • 14

    Karakousis CP, Emrich LJ, Rao U, Khalil M. Limb salvage in soft tissue sarcomas with selective combination of modalities. Eur J Surg Oncol 1991;17:7180.

    • Search Google Scholar
    • Export Citation
  • 15

    Rydholm A, Gustafson P, Rooser B et al. . Limb-sparing surgery without radiotherapy based on anatomic location of soft tissue sarcoma. J Clin Oncol 1991;9:17571765.

    • Search Google Scholar
    • Export Citation
  • 16

    Baldini EH, Goldberg J, Jenner C et al. . Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk. J Clin Oncol 1999;17:32523259.

    • Search Google Scholar
    • Export Citation
  • 17

    Alektiar KM, Leung D, Zelefsky MJ, Brennan MF. Adjuvant radiation for stage II-B soft tissue sarcoma of the extremity. J Clin Oncol 2002;20:16431650.

    • Search Google Scholar
    • Export Citation
  • 18

    O'Sullivan B, Davis AM, Turcotte R et al. . Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002;359:22352241.

    • Search Google Scholar
    • Export Citation
  • 19

    O'Sullivan B, Davis AM, Turcotte R et al. . Five-year results of a randomized phase III trial of pre-operative vs postoperative radiotherapy in extremity soft tissue sarcoma. Paper presented at: Annual Meeting Proceedings of the American Society of Clinical Oncology, June 6, 2004; New Orleans, LA.

    • Search Google Scholar
    • Export Citation
  • 20

    Stoeckle E, Coindre JM, Bonvalot S et al. . Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 2001;92:359368.

    • Search Google Scholar
    • Export Citation
  • 21

    Pisters PW, O'Sullivan B. Retroperitoneal sarcomas: combined modality treatment approaches. Curr Opin Oncol 2002;14:400405.

  • 22

    Crist WM, Anderson JR, Meza JL et al. . Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 2001;19:30913102.

    • Search Google Scholar
    • Export Citation
  • 23

    Tierney JF, Mosseri V, Stewart LA et al. . Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials. Br J Cancer 1995;72:469475.

    • Search Google Scholar
    • Export Citation
  • 24

    Zalupski MM, Ryan JR, Hussein ME, Balker LH. Defining the role of adjuvant chemotherapy for patients with soft tissue sarcoma of the extremities. In: Salmon SE, ed. Adjuvant Therapy of Cancer VII. Philadelphia, PA: JB Lippincott; 1993:385392.

    • Search Google Scholar
    • Export Citation
  • 25

    Sarcoma Meta-Analysis Collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet 1997;350:16471654.

    • Search Google Scholar
    • Export Citation
  • 26

    Antman K, Crowley J, Balcerzak SP et al. . An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol 1993;11:12761285.

    • Search Google Scholar
    • Export Citation
  • 27

    Edmonson JH, Ryan LM, Blum RH et al. . Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol 1993;11:12691275.

    • Search Google Scholar
    • Export Citation
  • 28

    Frustaci S, Gherlinzoni F, De Paoli A et al. . Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol 2001;19:12381247.

    • Search Google Scholar
    • Export Citation
  • 29

    Frustaci S, De Paoli A, Bidoli E et al. . Ifosfamide in the adjuvant therapy of soft tissue sarcomas. Oncology 2003;65 (suppl 2):8084.

  • 30

    DeLaney TF, Spiro IJ, Suit HD et al. . Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys 2003;56:11171127.

    • Search Google Scholar
    • Export Citation
  • 31

    Eilber FC, Brennan MF, Eilber FR et al. . Validation of the postoperative nomogram for 12-year sarcoma-specific mortality. Cancer 2004;101:22702275.

    • Search Google Scholar
    • Export Citation
  • 32

    Gortzak E, Azzarelli A, Buesa J et al. . A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma. Eur J Cancer 2001;37:10961103.

    • Search Google Scholar
    • Export Citation
  • 33

    Cormier JN, Huang X, Xing Y et al. . Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes. J Clin Oncol 2004;22:45674574.

    • Search Google Scholar
    • Export Citation
  • 34

    Eilber FC, Eilber FR, Eckardt J et al. . The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma. Ann Surg 2004;240:686695; discussion 695–687.

    • Search Google Scholar
    • Export Citation
  • 35

    Grobmyer SR, Maki RG, Demetri GD et al. . Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol 2004;15:16671672.

    • Search Google Scholar
    • Export Citation
  • 36

    Pearlstone DB, Pisters PW, Bold RJ et al. . Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer 1999;85:8592.

    • Search Google Scholar
    • Export Citation
  • 37

    Issels RD, Abdel-Rahman S, Wendtner C et al. . Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study. Eur J Cancer 2001;37:15991608.

    • Search Google Scholar
    • Export Citation
  • 38

    Wendtner CM, Abdel-Rahman S, Krych M et al. . Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas. J Clin Oncol 2002;20:31563164.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 770 314 5
PDF Downloads 675 333 7
EPUB Downloads 0 0 0